A Pilot Investigation of Ciclesonide When Administered as a Hypotonic Versus an Isotonic Formulation of Ciclesonide Nasal Spray

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: Allergic Rhinitis

In brief

The purpose of this study is to measure the amount of a nasal steroid spray (ciclesonide) absorbed by the tissue in the nose 2 hours after having this study drug sprayed in the nose

Key facts

Study ID

NCT00793858

Run by

University of Chicago

People needed

0

Starts

2009-02-01

Last updated by the study team

2013-06-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females 18 years of age or older.
• History of perennial allergic rhinitis for at least 1 year prior to screening.
• Positive skin test to perennial allergen.

You may not qualify if…

• Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.
• Pregnant or lactating women.
• Upper respiratory infection within 14 days of study start.
• Active asthma requiring treatment with inhaled or systemic steroids.
• Use of any form of nasal spray during the previous month.

Where it is running

• University of Chicago Medical Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.